Profile of HIV pre-exposure prophylaxis users treated at the university hospital of northern Tocantins
DOI:
https://doi.org/10.26694/repis.v11i1.6536Keywords:
Pre-Exposure Prophylaxis, HIV, Disease Prevention, Sexually Transmitted InfectionsAbstract
Introduction: Human immunodeficiency virus (HIV) infection is a serious public health problem that can lead to acquired immunodeficiency syndrome (AIDS). In this context, HIV pre-exposure prophylaxis (PrEP) is a powerful technology that, when combined with other prevention methods, has an impact on reducing new infections with the virus. The objective was to analyze the profile of PrEP users treated at the University Hospital of Northern Tocantins. Design: This is an observational, retrospective, cross-sectional, descriptive study with a quantitative approach, using secondary data collected from the Medication Logistics Control System and medical records of all PrEP users. The research was conducted at the University Hospital of Northern Tocantins, from August 2024 to January 2025. Descriptive statistics of absolute and relative frequencies, mean, standard deviation, minimum and maximum values were used, and the chi-square test of independence and/or Fisher's exact test were performed in the Statistic Package for Social Sciences (SPSS) version 21. An alpha error of 5% and a confidence level of 95% were considered. Results: The profile of the 63 medical records of PrEP users was predominantly male, cisgender and homosexual, aged between 20 and 29 years, self-declared brown-skinned, and with a high level of education, from Araguaína-TO. Implications: Access to PrEP in the service has grown since its implementation, however, there is a need to create strategies to further popularize prophylaxis and reach other priority groups, such as bisexuals, transgender people, and sex workers.
References
Portilla Tamarit I. Rubio Aparicio M, Fuster RuizdeApodaca MJ, Portilla Tamarit J, Reus S, Portilla J. Health Related Quality of Life in People with Advanced HIV Disease, from 1996 to 2021: Systematic Review and Meta analysis. AIDS Behav. 2024 maio; 28; 1978–1998. Available from: https://link.springer.com/article/10.1007/s10461-024-04298-y.
UNAIDS. Join United Nations Programme on HIV/AIDS. Estatísticas. Geneva. 2023. Available from: https://unaids.org.br/estatisticas/
Dessie ZG, Zewotir T. Estigma relacionado ao HIV e fatores associados: uma revisão sistemática e meta-análise. Front. Public Health. 2024 july; 12 (1): 1356430. Available form: https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2024.1356430/full
Ministério da Saúde (BR). Protocolo Clínico e Diretrizes Terapêuticas para Profilaxia Pré- Exposição (PrEP) de Risco à Infecção pelo HIV [Internet].2022 [cited 2023 Mar 29]. Disponível em: https://www.gov.br/aids/pt-br/central-de-conteudo/pcdts/2017/hiv-aids/pcdt prep-versao-eletronica-22_09_2022.pdf/view
Pereira CHG, Dias FA, Miranda GS, Höfelmann DA, Rattmann YD. Avaliação do uso da Profilaxia Pré-Exposição ao HIV: coorte retrospectiva. Rev Bras Promoc Saúde [Internet]. 2021 nov [citado 2025 mar 6]; 34:10. Disponível em: https://ojs.unifor.br/RBPS/article/view/11550
Antonini M, Silva IE da, Elias HC, Gerin L, Oliveira AC, Reis RK. Barriers to Pre-Exposure Prophylaxis (PrEP) use for HIV: an integrative review. Rev Bras Enferm [Internet]. 2023 out [cited 2024 Dec 10]; 76(3):e20210963. Disponível em: https://doi.org/10.1590/0034-7167-2021-0963
Barbosa LC de A, Paixão JT dos S, Nascimento RT do, Antas LAV, Reis RK, Melo GC de. Pre-exposure prophylaxis (PrEP) to HIV in Alas, Brazil: characterization of users, adherence to the protocol and risk behavior for transmissible sexual habits (STIs). RSD [Internet]. 2022 Oct. [cited 2025 Mar 4];11(13):e214111334515. Available from: https://rsdjournal.org/index.php/rsd/article/view/34515.
World Health Organization. Targets of Sustainable Development Goal 3 [Internet]. Copenhagen: WHO Regional Office for Europe; [cited 2025 Mar 6]. Available from: https://www.who.int/europe/about-us/our-work/sustainable-development-goals/targets-of-sustainable-development-goal-3
Ministério da Saúde (BR). Relatório de monitoramento de profilaxias pré e pós-exposição ao HIV 2023. [Internet] 2023. [cited 2024 jan 30]. Disponível em: https://www.gov.br/aids/pt-br/central-de-conteudo/publicacoes/2024/relatorio-de-profilaxias-prep-e-pep-2022.pdf/view. Acesso em: 10 nov. 2024.
Instituto Brasileiro de Geografia e Estatística. Panorama do Censo Demográfico 2022. [Internet] 2022. Disponível em: https://censo2022.ibge.gov.br/panorama/. Acesso em: 22 dez. 2024.
Ministério da Saúde (BR). Boletim de Vigilância Epidemiológica HIV e AIDS 2024. Departamento de HIV/Aids, Tuberculose, Hepatites Virais e Infecções Sexualmente Transmissíveis [Internet]. 2024. [cited 2023 Mar 29]. Disponível em: https://www.gov.br/aids/pt-br/central-de-conteudo/boletins-epidemiologicos/2024/boletim_hiv_aids_2024e.pdf/view
Grangeiro A, Massa PA, Escuder MM, Zucchi EM, Sala EA, Oliveira EA, et al. Oferta de prep em organizações comunitárias: estudo comparativo com serviços convencionais. Rev Saúde Pública [Internet]. 2024;58:9s. Available from: https://doi.org/10.11606/s1518-8787.2024058005914
Allen DC, Rabionete SE, Popovici I, Zorrilla CD. Acknowledging and addressing the gender disparity in pre-exposure prophylaxis use for HIV prevention. J Pharm Health Serv Res [Internet], 2022; [cited 2024 Dec 10]; 13(3): 168-171. Available from: https://academic.oup.com/jphsr/article/13/3/168/6645632?login=false.
Kerrigan D, Yonamine K, O’Rourke A, Karver TS, Davis WW, Metzner AA, et al. 1843.Exploring Cisgender Women's HIV Pre-Exposure Prophylaxis (PrEP) Needs and Preferences Across Settings: the Roles of Social-Structural Factors. Open Forum Infect Dis.
Nov 27;10(Suppl 2): ofad500.1671. doi: 10.1093/ofid/ofad500.1671. PMCID: PMC10678848. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC10678848/
Torres TS, Coelho LE, Konda KA, Vega-Ramirez EH, Elorreaga OA, Diaz-Sosa D, et al. Low socioeconomic status is associated with self-reported HIV positive status among young MSM in Brazil and Peru. BMC Infect Dis 2021 july; 21(726): p 1-9. Available form: https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-021-06455-3
Sousa KE, Queiroz RO, da Silva M, Góes HL de F. Perfil dos usuários de uma unidade especializada no Paraná sobre Profilaxia Pré-Exposição ao HIV/AIDS. Rev. Enferm. Atual In Derme [Internet]. 2022 maio [citado 2025 mar 6];96 (38): e-021255. Disponível em: https://www.revistaenfermagematual.com.br/index.php/revista/article/view/1331
Rotsaert, A., Reyniers, T., Jacobs, B. K., Vanbaelen, T., Burm, C., Kenyon, C. PrEP user profiles, dynamics of PrEP use and follow‐up: a cohort analysis at a Belgian HIV centre (2017–2020). J. Int. AIDS Soc. 2022; 25: e25953. Available from: https://onlinelibrary.wiley.com/doi/10.1002/jia2.25953
Pimenta MC, Bermúdez XP, Godoi AMM, Maksud I, Benedetti M, Kauss B, et al. Barreiras e facilitadores do acesso de populações vulneráveis à PrEP no Brasil: Estudo ImPrEP Stakeholders. Cad Saúde Pública [Internet]. 2022; 38(1):e00290620. Available from: https://doi.org/10.1590/0102-311X00290620
Rodrigues SS, de Andrade AFSM, da Silva K, da Silva ÂM, Martins-Filho PR. Demographic, socioeconomic, and health structure factors associated with the use of HIV pre-exposure prophylaxis in Brazil: A nationwide ecological study. Int J STD AIDS. 2024 Aug; 35(9):721-726. Available from: https://pubmed.ncbi.nlm.nih.gov/38720580/
Ministério da Saúde (BR). Painel de PrEP. Departamento de HIV/Aids, Tuberculose, Hepatites Virais e Infecções Sexualmente Transmissíveis [Internet].2024b [cited 2023 Mar 29].Disponível em: https://www.gov.br/aids/pt-br/assuntos/prevencao-combinada/prep-profilaxia-pre-exposicao/painel-prep
Batista AT, Saldanha AAW, Furtado FMF. Vantagens e desvantagens percebidas pelas populações chaves no uso da profilaxia pré-exposição. Mudanças, [Internet]. 2020 dez. [cited 2025 Mar 04]; 28(2): 11-20. Disponível em: https://pepsic.bvsalud.org/scielo.php?script=sci_arttext&pid=S0104-32692020000200002
Barbosa LC de A, Paixão JT dos S, Nascimento RT do, Antas LAV, Reis RK, Melo GC de. HIV pre-exposure prophylaxis (PrEP) in a Brazilian clinical setting: Adherence, adverse events, sexual behavior, and sexually transmitted infections. rch. Sex. Behav. [Internet]. 2022 Jan [cited 2025 Mar 4]; 51(5): 2603-2611. Available from: https://link.springer.com/article/10.1007/s10508-021-02112-7
Segosebe K, Kirwan M, Davis KC. Barriers to Condom Negotiation and Use Among Female Sex Workers in the United States and United States-Mexico Border Cities: A Systematic Review. AIDS Behav. 2023 feb; 27: 2855–2864. Available form: https://link.springer.com/article/10.1007/s10461-023-04009-z.
Schreeb SV, Pedersen SK, Christensen H, Jorgsensen KM, Harritshoi LM, Hertz FB, et al.
Questioning risk compensation: pre-exposure prophylaxis (PrEP) and sexually transmitted infections among men who have sex with men, capital region of Denmark, 2019 to 2022. Euro Surveill. 2024 mar; 29(13): 2300451. Available form: https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2024.29.13.2300451
Roth MJMC, Valderrama MR., Acras J S, Moro M G, Lehmkuhl JVB, Pazin, DC. Analysis of sexually transmitted infections in PrEP users: Population assessment in Curitiba, Brazil. Braz J Sex Transm Dis. 2021; 33. Available from: https://www.bjstd.org/revista/article/view/1178/1153
Ferreira AM, Silva NCR, Paula L, Andrade HS. Pre-exposure prophylaxis as prevention strategy in the HIV transmission: characterization of the user. Rev Prev Infec e Saúde [Internet]. 2022 mar. [citado 5 de março de 2025];8(1). Disponível em: https://periodicos.ufpi.br/index.php/repis/article/view/2220
Costa AR, Barros JF, Lima VP, Magalhães C, Silva HKR, Deusdará R, Lapa SJ. Substance Use and Risky Sexual Behavior in the PrEP Outpatient Clinic at the University Hospital of Brasília. Trop. Med. Infect. Dis [Internet]. 2023 Jun; 8 (6): 323. Available from: https://doi.org/10.3390/tropicalmed8060323
Coelho LS, Pádua M F. Profilaxia Pré-Exposição (PrEP) ao HIV na Atenção Primária à Saúde: reduzindo iniquidades. APS [Internet]. 25º de janeiro de 2024 [citado 2025 Mar 2025];5(3):118-24. Disponível em: https://apsemrevista.org/aps/article/view/300
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Samanta Cunha Mesquita, Joaquim Guerra de Oliveira Neto, Francisca Nayara dos Santos Madeira, Patrícia Alves de Mendonça Cavalcante, Lucianna Mirelle de Sá Trabulsi, Francisco Maurílio da Silva Carrias
This work is licensed under a Creative Commons Attribution 4.0 International License.
